Pharmacogenomics Corner

Back to articles

Use of pharmacogenomic information results in numerous clinical benefits


Incorporating pharmacogenomic information into prescribing decisions increases patient–provider communications, patient recall of medication changes, and provider knowledge of pharmacogenomics, according to results of an observational study published in The Pharmacogenomics Journal.


Borden BA, et al. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019;[Epub ahead of print].

Mills R, et al. Delivering pharmacogenetic testing in a primary care setting. Pharmacogenomics Pers Med. 2013;6:105–12.